These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 110683)

  • 21. Effects of nonionic, ionic, and dipolar ionic detergents and EDTA on the Brucella cell envelope.
    Moriyon I; Berman DT
    J Bacteriol; 1982 Nov; 152(2):822-8. PubMed ID: 6813315
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Isolation, purification, and partial characterization of Brucella abortus matrix protein.
    Moriyon I; Berman DT
    Infect Immun; 1983 Jan; 39(1):394-402. PubMed ID: 6401696
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Immunochemical characterization of Brucella lipopolysaccharides and polysaccharides.
    Moreno E; Speth SL; Jones LM; Berman DT
    Infect Immun; 1981 Jan; 31(1):214-22. PubMed ID: 6163716
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Immunochemical characteristics and serologic properties of lipopolysaccharides isolated from various Brucella species using various extraction methods].
    Malikov VE; Dranovskaia EA; Vysotskiĭ VV
    Zh Mikrobiol Epidemiol Immunobiol; 1989 Mar; (3):22-7. PubMed ID: 2500818
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Chemical analysis of the outer membrane and other layers of the cell envelope of Acinetobacter sp.
    Thorne KJ; Thornley MJ; Glauert AM
    J Bacteriol; 1973 Oct; 116(1):410-7. PubMed ID: 4745422
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Characterization of Brucella abortus O-polysaccharide and core lipopolysaccharide mutants and demonstration that a complete core is required for rough vaccines to be efficient against Brucella abortus and Brucella ovis in the mouse model.
    Monreal D; Grilló MJ; González D; Marín CM; De Miguel MJ; López-Goñi I; Blasco JM; Cloeckaert A; Moriyón I
    Infect Immun; 2003 Jun; 71(6):3261-71. PubMed ID: 12761107
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ultrastructural localization of characterized antigens of Brucella abortus and distribution among different biotypes.
    Raybould TJ; Beesley JE; Chantler S
    Infect Immun; 1981 Apr; 32(1):318-22. PubMed ID: 6783549
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Lipids of cell walls of Pseudomonas aeruginosa and Brucella abortus.
    Bobo RA; Eagon RG
    Can J Microbiol; 1968 May; 14(5):503-13. PubMed ID: 4969280
    [No Abstract]   [Full Text] [Related]  

  • 29. [Chemical and serological studies of Brucella abortus 99 bacterial wall fractions].
    Tsankova K
    Vet Med Nauki; 1977; 14(1):47-53. PubMed ID: 408968
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Isolation and characterization of toxic fractions from Brucella abortus.
    Tabatabai LB; Deyoe BL; Ritchie AE
    Infect Immun; 1979 Nov; 26(2):668-79. PubMed ID: 121112
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Structure and constituents of Brucella. Characterization and biological properties of the fractions].
    Dubray G; Plommet M
    Dev Biol Stand; 1976; 31():68-91. PubMed ID: 1261752
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of protein components of different species and strains of Brucella.
    Oñate A; Folch H
    Zentralbl Veterinarmed B; 1989 Jul; 36(5):397-400. PubMed ID: 2506718
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Brucella outer membrane lipoprotein shares antigenic determinants with Escherichia coli Braun lipoprotein and is exposed on the cell surface.
    Gómez-Miguel MJ; Moriyón I; López J
    Infect Immun; 1987 Jan; 55(1):258-62. PubMed ID: 2432014
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Outer membrane proteins of Brucella abortus: isolation and characterization.
    Verstreate DR; Creasy MT; Caveney NT; Baldwin CL; Blab MW; Winter AJ
    Infect Immun; 1982 Mar; 35(3):979-89. PubMed ID: 6802764
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ingestion and intracellular survival of Brucella abortus in human and bovine polymorphonuclear leukocytes.
    Riley LK; Robertson DC
    Infect Immun; 1984 Oct; 46(1):224-30. PubMed ID: 6090315
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Free lipids from Brucella abortus Bang. 4. Nature of the phosphatides and their fatty acid composition].
    Thiele OW; Busse D; Hoffmann K
    Eur J Biochem; 1968 Sep; 5(4):513-9. PubMed ID: 4972385
    [No Abstract]   [Full Text] [Related]  

  • 37. The chemical basis of the virulence of Brucella abortus. 8. The identity of purified immunogenic material from culture filtrate and from the cell-wall of Brucella abortus grown in vitro.
    Ellwood DC; Keppie J; Smith H
    Br J Exp Pathol; 1967 Feb; 48(1):28-39. PubMed ID: 4960056
    [No Abstract]   [Full Text] [Related]  

  • 38. Comparative immune responses to native cell envelope antigens and the hot sodium dodecyl sulfate insoluble fraction (PG) of Brucella abortus in cattle and mice.
    Winter AJ; Rowe GE
    Vet Immunol Immunopathol; 1988 Mar; 18(2):149-63. PubMed ID: 3133872
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Penetration and intracellular growth of Brucella abortus in nonphagocytic cells in vitro.
    Detilleux PG; Deyoe BL; Cheville NF
    Infect Immun; 1990 Jul; 58(7):2320-8. PubMed ID: 2114362
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Biological activities of Brucella abortus lipopolysaccharides.
    Moreno E; Berman DT; Boettcher LA
    Infect Immun; 1981 Jan; 31(1):362-70. PubMed ID: 6783538
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.